Harmonization: the Sample, the Measurement, and the Report
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Harmonization of clinical laboratory results means that results are comparable irrespective of the measurement procedure used and where or when a measurement was made. Har- monization of test results includes consideration of pre-analytical, analytical, and post-ana- lytical aspects. Progress has been made in each of these aspects, but there is currently poor coordination of the effort among different professional organizations in different coun- tries. Pre-analytical considerations include terminology for the order, instructions for prepa- ration of the patient, collection of the samples, and handling and transportation of the sam- ples to the laboratory. Key analytical considerations include calibration traceability to a ref- erence system, commutability of reference materials used in a traceability scheme, and specificity of the measurement of the biomolecule of interest. International organizations addressing harmonization include the International Federation for Clinical Chemistry and Laboratory Medicine, the World Health Organization, and the recently formed International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR). The ICHCLR will provide a prioritization process for measurands and a service to coordinate global harmoni- zation activities to avoid duplication of effort. Post-analytical considerations include nomen- clature, units, significant figures, and reference intervals or decision values for results. Har- monization in all of these areas is necessary for optimal laboratory service. This review summarizes the status of harmonization in each of these areas and describes activities un- derway to achieve the goal of fully harmonized clinical laboratory testing.
Abstract
Harmonization of clinical laboratory results means that results are comparable irrespective of the measurement procedure used and where or when a measurement was made. Har- monization of test results includes consideration of pre-analytical, analytical, and post-ana- lytical aspects. Progress has been made in each of these aspects, but there is currently poor coordination of the effort among different professional organizations in different coun- tries. Pre-analytical considerations include terminology for the order, instructions for prepa- ration of the patient, collection of the samples, and handling and transportation of the sam- ples to the laboratory. Key analytical considerations include calibration traceability to a ref- erence system, commutability of reference materials used in a traceability scheme, and specificity of the measurement of the biomolecule of interest. International organizations addressing harmonization include the International Federation for Clinical Chemistry and Laboratory Medicine, the World Health Organization, and the recently formed International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR). The ICHCLR will provide a prioritization process for measurands and a service to coordinate global harmoni- zation activities to avoid duplication of effort. Post-analytical considerations include nomen- clature, units, significant figures, and reference intervals or decision values for results. Har- monization in all of these areas is necessary for optimal laboratory service. This review summarizes the status of harmonization in each of these areas and describes activities un- derway to achieve the goal of fully harmonized clinical laboratory testing.
참고문헌 (47)
- Sacks DB., "Tietz textbook of clinical chemistry and molecular diagnostics. 5th eds", pp.719~ (2012), Elsevier
- Sacks DB, "Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus", Clin Chem, 57, pp.1~47 (2011)
- Wu AHB, "Tietz clinical guide to laboratory tests. 4th ed" (2006), WB Saunders
- Clinical and Laboratory Standards Institute, "Expression of measurement uncertainty in laboratory medicine; Approved Guideline. CLSI document EP29-A", Clinical and Laboratory Standards Institute, ~ (2012)
- White GH, "Basics of estimating measurement uncertainty", Clin Biochem Rev, 29(1), pp.53~60 (2008)
- Vesper HW, "Traceability in laboratory medicine", Clin Chem, 55, pp.1067~1075 (2009)
- "ISO 17511:2003. In vitro diagnostic medical devices -measurement of quantities in biological samples-metrological traceability of values assigned to calibrators and control materials", 2003 International Organization for Standardization Geneva, ~ (2003)
- Blirup-Jensen S, "Protein standardization II: dry mass determination procedure for the determination of the dry mass of a pure protein preparation", Clin Chem Lab Med, 39, pp.1090~1097 (2001)
- Zegers I, "Characterization of the new serum protein reference material ERM-DA470k", IFCC: value assignment by immunoassay, 2010, pp.56, 1880~1888
- Sturgeon CM, "Variation in parathyroid hormone immunoassay results--a critical governance issue in the management of chronic kidney disease", Nephrol Dial Transplant, 26, pp.3440~3445 (2011)
- Thygesen K, "Joint ESC", ACCF, WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction, pp.Circulation, 2012[DOI]
- "Toolbox of technical procedures to be considered when developing a process to achieve harmonization for a measurand" (2013)[URL]
- Van Houcke SK, "Harmonization of immunoassays to the all-procedure trimmed mean - proof of concept by use of data from the insulin standardization project", Clin Chem Lab Med, 51, pp.103~105 (2013)
- Miller WG, "Why commutability matters", Clin Chem, 52, pp.553~554 (2006)
- The Joint Committee for Guides in metrology, "International vocabulary of metrology- Basic and general concepts and associated terms. VIM. 3rd edn", pp.200~ (2008), JCGM
- Miller WG, "Commutability still matters", Clin Chem, 59, pp.1291~1293 (2013)
- Vesper HW, "Reference materials and commutability", Clin Biochem Rev, 28, pp.139~147 (2007)
- Fasce CF Jr, "A discussion of enzyme reference materials: applications and specifications", Clin Chem, 19, pp.5~9 (1973)
- Clinical and Laboratory Standards Institute, "Characterization and qualification of commutable reference materials for laboratory medicine; Approved guideline. CLSI Document EP30-A", CLSI, ~ (2010)
- Wu AH, "Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I", Clin Chem, 44, pp.1198~1208 (1998)
- Gillery P, "Progress toward standardization: an IFCC Scientific Division Perspective", Clin Chem Lab Med, 51, pp.915~918 (2013)
- "Directive 98", 79, Official Journal of the European Communities, pp.1998, L331[DOI]
- "Joint Committee for Traceability in Laboratory Medicine (JCTLM)"[URL]
- Miller WG, "Roadmap for harmonization of clinical laboratory measurement procedures", Clin Chem, 57, pp.1108~1117 (2011)
- "International consortium for harmonization of clinical laboratory results (ICHCLR)" (2013)[URL]
- Jones R, "NLMC-more than just for pathology", Bull Roy Coll Pathol, 160, pp.233~236 (2012)
- Funder JW, "Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline", J Clin Endocrinol Metab, 93, pp.3266~3281 (2008)
- Kilpatrick ES, "Glycemic control in the 12 months following a change to SI hemoglobin A1c reporting units", Clin Chem, 59, pp.1457~1460 (2013)
- "The Unified Code for Units of Measure" (2013)[URL]
- "Pathology Harmony"[URL]
- "Royal College of Pathologists of Australasia, Pathology terminology and information standardization downloads"[URL]
- "International Federation of Clinical Chemistry and Laboratory Medicine, Nomenclature, Properties and Units (C-NPU) in collaboration with International Union of Pure and Applied Chemistry (IUPAC)"[URL]
- Plebani M, "Harmonization in laboratory medicine: the complete picture", Clin Chem Lab Med, 51, pp.741~751 (2013)
- Jones GR, "The case for common reference intervals", Clin Biochem Rev, 25, pp.99~104 (2004)
- Jassam N, "Can current analytical quality performance of UK clinical laboratories support evidence-based guidelines for diabetes and ischaemic heart disease? --A pilot study and a proposal", Clin Chem Lab Med, 51, pp.1579~1584 (2013)
- Jones GR, "Laboratory reporting of urine protein and albumin", Clin Biochem Rev, 32, pp.103~107 (2011)
- Sikaris K, "Application of the Stockholm hierarchy to defining the quality of reference intervals and clinical decision limits", Clin Biochem Rev, 33, pp.141~148 (2012)
- Rustad P, "The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties", Scand J Clin Lab Invest, 64, pp.271~284 (2004)
- Ozarda Y, "Committee on Reference Intervals and Decision Limits (C-RIDL), International Federation for Clinical Chemistry and Laboratory Medicine. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values", Clin Chem Lab Med, 51, pp.1027~1040 (2013)
- Berg J, "Pathology Harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory", Ann Clin Biochem, 48, pp.195~197 (2011)
- Koerbin G, "On behalf of the AACB Committee for Common Reference Intervals. Evidence-based approach to harmonized reference intervals", Clin Chim Acta (2013)[DOI]
- Jones G, "Reference intervals", Clin Biochem Rev, 29(1), pp.93~97 (2008)
- Jones GR, "‘Allowable Limits of Performance’ for External Quality Assurance Programs - an Approach to Application of the Stockholm Criteria by the RCPA Quality Assurance Programs", Clin Biochem Rev, 33, pp.133~139 (2012)
- "Allowable limits of performance for the Royal College of Pathologists of Australasia Quality Assurance Program"[URL]
- Jones GR, "Validating common reference intervals in routine laboratories", Clin Chim Acta (2013)[DOI]
- Panteghini M, "Obtaining reference intervals traceable to reference measurement systems: is it possible, who is responsible, what is the strategy?", Clin Chem Lab Med, 50, pp.813~817 (2011)
